FDA Issues a Recall of All Zantac Products
In April 2020, the FDA recalled all forms of Zantac, including prescription and over-the-counter versions, due to alarmingly high levels of the harmful compound NDMA. Urging patients to cease using ranitidine, the FDA also asked manufacturers to halt the production and recall both branded and generic versions of the drug. Even before this directive, several retailers and companies like CVS, Walmart, and Sandoz had proactively suspended Zantac sales pending further research outcomes.
Zantac Manufacturers Identified in Several Lawsuits
Manufacturers like Sanofi-Aventis U.S. LLC, Sanofi U.S. Services Inc., Chattem Inc., Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are implicated in various lawsuits concerning the brand name Zantac. However, in July 2021, due to federal legal protections, Judge Robin L. Rosenberg ruled to dismiss cases against generic drug producers such as Teva Pharmaceuticals and Amneal Pharmaceuticals.
Contact a Zantac Lawsuit Attorney
If you have been affected due to Zantac exposure, we urge you to file a claim. We have experienced lawyers ready to guide you through the process.
Get in touch today to take your first step towards compensation and peace of mind.
